Breaking News
19 hours ago
Simantini Singh Deo

CBC India secures exclusive distribution rights for Metalco-Alupack's seamless anodized aluminium packaging, targeting sterile API supply chains across India.
Simantini Singh Deo

Suven Life's Masupirdine Phase 3 trial clears DSMB interim review with no modifications as global enrollment reaches 88%.
Simantini Singh Deo

Glenmark enters US market with generic Lacosamide Injection USP, a Vimpat® equivalent targeting a $15.2M annual hospital-use segment.
Simantini Singh Deo

ModernaTX secures FDA biologics licensure for MNEXSPIKE under STN 125835, with a layered approval record spanning May–September 2025.
Simantini Singh Deo
